Topic: Rectal cancer
Document Owner: Head of evidence and quality hub, national cancer control programme
National Group: National cancer control programme
Effective From: 11 December 2024
Unfortunately, you are using an outdated browser. Please, upgrade your browser to improve your experience with HSE. The list of supported browsers:
The purpose of this National Clinical Guideline is to provide evidence based recommendations on the neoadjuvant treatment of patients with rectal cancer through the integration of the best research evidence with clinical expertise, patient values and experiences.